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A B S T R A C T
Objectives: To investigate the feasibility of a high resolution optical imaging strategy for myocardial
infarction.
Background: Near-infrared approaches to imaging cardiovascular disease enable visualization of
disease-associated biological processes in vivo. However, even at the scale of small animals, the strong
scattering of light prevents high resolution imaging after the ﬁrst 1–2 mm of tissue, leading to degraded
signal localization.
Methods: Multispectral optoacoustic tomography (MSOT) was used to non-invasively image myocardial
infarction (MI) in a murine model of coronary artery ligation at resolutions not possible with current
deep-tissue optical imaging methods. Post-MI imaging was based on resolving the spectral absorption
signature of a dendritic polyglycerol sulfate-based (dPGS) near-infrared imaging agent targeted to P- and
L-selectin.
Results: In vivo imaging succeeded in detection of the agent in the injured myocardium after intravenous
injection. The high anatomic resolution (<200 mm) achieved by the described method allowed signals
originating in the infarcted heart to be distinguished from uptake in adjacent regions. Histological
analysis found dPGS signal in infarcted areas, originating from leukocytes and endothelial cells.
Conclusions: MSOT imaging of myocardial infarction provides non-invasive visualization of optical
contrast with a high spatial resolution that is not degraded by the scattering of light.
 2012 Elsevier GmbH. 
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Open access under CC BY-NC-ND license. 1. Introduction
In vivo optical imaging in the near-infrared (NIR) spectrum
plays a signiﬁcant role in cardiovascular research. Intravascular
molecular imaging with a NIR ﬂuorescence (NIRF) catheter has been
demonstrated as a highly promising method for detecting protease
activity in atherosclerotic plaques [1,2]. Non-invasive optical
imaging of processes implicated in cardiovascular disease has also
been reported. For example, visualization of macrophage inﬁltration
using ﬂuorescent nanoparticles [3] and investigations of monocyte
recruitment for infarct healing [4] have been performed using
Fluorescence Molecular Tomography (FMT). However, optical* Corresponding author at: Technische Universita¨t Mu¨nchen, Lehrstuhl fu¨r
Biologische Bildgebung, Ismaninger Str. 22, 81675 Mu¨nchen, Germany.
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Open access under CC BY-NC-ND license. imaging methods are limited in performance by scattering, which
degrades the spatial resolution and overall accuracy at increased
penetration depths [5]. Optoacoustic imaging, in particular Multi-
spectral Optoacoustic Tomography (MSOT) offers a way around this
problem by producing images of speciﬁc optical contrast at
ultrasound resolutions.
Optoacoustic imaging is based on the optoacoustic (photo-
acoustic) effect, whereby short (usually nanosecond range) pulses of
light that are absorbed in tissue give rise to broadband ultrasound
waves, which can be detected non-invasively [5]. Since ultrasound
scatters orders of magnitude less than light in tissue, optoacoustic
methods can offer high-resolution optical images in tissues up to
several centimeters deep. The signal observed on optoacoustic
images is directly proportional to the local absorption coefﬁcient. By
applying multiple excitation wavelengths and tomographic signal
detection, MSOT can provide images of speciﬁc chromophores
(absorbers) based on their unique spectra [6–8]. Spectral unmixing
methods have been shown to resolve oxygenated and deoxygenated
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administered photo-absorbing agents including organic dyes [7,10]
and nanoparticles [11,12]. Applied to cardiovascular imaging, MSOT
has demonstrated anatomical visualization of the mouse heart and
blood vessels [13]. Motion correction techniques for multi-
wavelength excitation [14] have also been developed, allowing
high-resolution spectral unmixing of the beating heart. In addition,
MSOT detection of molecular imaging agents relevant to cardiovas-
cular disease was demonstrated by resolving matrix–metallopro-
teinase (MMP) activity in human atherosclerotic plaque specimens
[15]. Ex vivo optoacoustic imaging of excised mouse hearts has
demonstrated visualization of infarcted regions with reduced
absorption compared to healthy tissue, resulting from reduced
hemoglobin concentration due to ischemia [16].
In this study, we investigated the previously undocumented
ability of MSOT to image myocardial infarction in vivo using an
exogenously administered targeted optical agent. Speciﬁcally, we
hypothesized that the detection of an inﬂammation-targeted NIR
imaging agent based on dendritic polyglycerol sulfates (dPGS) is
possible in mice in vivo and that it could be imaged within infarcted
myocardium in high resolution. Results were contrasted to
histological analysis and macroscopic cryosection NIRF imaging
of the dPGS distribution within the infarcted myocardium, serving
as the gold standard.
2. Methods
2.1. Animal handling
All procedures involving animals were approved by local
subcommittee on animal research. We used a total of 15 adult
female C57BL/6 mice in this study. The mice were anesthetized for
all surgical and imaging procedures by general inhalation
anesthesia (Isoﬂuorane 1.5–2.5% vol., plus 2 l O2). We induced
myocardial infarction by permanent ligation of the left anterior
descending artery (LAD) leading to a transmural infarct as
previously described [3].
2.2. Imaging agent
Dendritic polyglycerol sulfates (dPGS) are highly branched
structures with a polyanionic sulfate surface that can interact via a
multivalent binding mechanism with basic protein motifs. It has
been shown that dPGS binds to P- and L-selectin [17], and imaging
studies with NIR conjugates proved selective accumulation in
inﬂamed joints [18] in a preclinical model of arthritis.
The dPGS-NIR dye conjugate was synthesized by anionic
polymerization of glycidol, modiﬁcation with an aliphatic azido-
linker chain followed by the sulfation reaction. To this linker, NIR
dye (6S-ICG propargyl; mivenion GmbH, Berlin, Germany) was
conjugated followed by HPLC puriﬁcation yielding dPGS-NIR with
a mean dye-to-polymer ratio of 3 and an average molecular weight
of 19000 Da. Absorption maxima in PBS were 710 and 795 nm,
ﬂuorescence emission maximum 810 nm. The ﬂuorescence
quantum yield in water was below 1% due to intramolecular
quenching. The high absorption per polymer due to multiple dye
attachment, the absorption peak around 800 nm, and the low
quantum yield provide a NIR agent with favorable properties for
detection by MSOT based on absorption.
For ex vivo histology, dPGS-ICC dye was used. This conjugate is
the structural analog of dPGS-NIR employing a ﬂuorophore with
visible ﬂuorescence (ICC propargyl: 550 nm absorption, 570 nm
emission peak, mivenion GmbH) enabling detection in standard
ﬂuorescence microscopes [18]. In addition, the corresponding
nonspeciﬁc agent based on the same polymer but without
sulfation, dPG-ICC, was applied for control purposes.2.3. MSOT imaging system
All MSOT imaging experiments were performed using a real-
time imaging system that has been described previously [13,19].
Optical excitation was provided by a Q-switched Nd:YAG laser
with a pulse duration around 10 ns and repetition rate of 10 pulses/
s, which pumped an optical parametric oscillator (OPO) with a
wavelength tuning range in the near-infrared from 700 nm to
950 nm. Light was delivered by a ﬁber bundle divided into 10
output arms to illuminate the subject being imaged from multiple
angles around the imaging plane. Optoacoustic signals were
measured using a 64-element concave (1728 active arc) transducer
array with a central frequency of 5 MHz. One transverse slice was
acquired from each laser pulse, resulting in a frame-rate of 10 Hz.
The acquisition time per frame is 32 ms for a 2 cm ﬁeld of view
(time taken for optoacoustic signals to propagate to the transducer
array). Image reconstruction took less than 100 ms, allowing
imaging in real-time. The in-plane resolution is in the range of
150–200 mm. During imaging, the ﬁber bundle outputs and
transducer array were stationary, while the subject could be
translated to capture different transverse slices. Measurements
took place in a temperature-controlled water bath for acoustic
coupling. An animal holder with a thin polyethylene membrane
prevented direct contact between the mouse and the water.
2.4. Phantom imaging
To verify optoacoustic detection of the dPGS-NIR spectrum
under controlled conditions, we imaged a solution of the agent
included in the center of a cylindrical, light-scattering phantom.
A stock solution of the agent was prepared by adding 1%
Albumin (Carl Roth, Karlsruhe, Germany) by weight to 250 nM
dPGS-NIR in PBS. The Albumin was included to simulate in vivo
conditions for the agent. For use as a standard of reference, we
recorded the extinction spectrum of dPGS-NIR in a spectrometer
(USB2000 VIS-NIR, Ocean Optics, Dunedin, Florida). We then
performed phantom measurements for validation of MSOT detec-
tion of the dPGS-NIR absorption proﬁle. The phantom consisted of
1.3% by weight of Agar (Sigma–Aldrich, Saint Louis, Missouri)
molded into a cylinder of 2 cm diameter. 6% by volume of Intralipid
20% emulsion (Sigma–Aldrich) was added to the solution to obtain a
background reduced optical scattering coefﬁcient ms’  10 cm1. A
plastic tube of 3 mm inner diameter containing the stock solution of
dPGS-NIR was included at the center of the cylinder. Phantom
imaging was performed in the same MSOT setup as the in vivo
experiments. We applied excitation wavelengths from 690 nm to
900 nm in steps of 5 nm. For each wavelength we recorded and
averaged optoacoustic signals from 50 frames (laser pulses).
2.5. Experimental protocol for in vivo MSOT
Mice were imaged on day 2 following myocardial infarction, a
time point corresponding to a ﬁrst peak of leukocyte inﬂux in the
injured myocardium [20,21]. Isoﬂuorane anesthesia was applied
for the duration of the experiments. Prior to MSOT imaging, hair
was removed from the chest region using chemical depilation. A
catheter was then inserted into the tail vein and the mice were
placed in the prone position in the MSOT imaging system. A
volume of interest ranging from the liver to the heart was selected
by inspection of live MSOT images. The following 8 excitation
wavelengths were selected for correspondence with the major
turning points in the absorption spectra of the dPGS-NIR and
hemoglobin: 710 nm, 730 nm, 760 nm, 790 nm, 800 nm, 820 nm,
850 nm, 900 nm. For each wavelength we recorded 100 individual
frames, that is, 100 laser pulses or 10 s. At each time point, the
region of interest was scanned with a pitch of 1 mm. Imaging was
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after injection. The injected dose of dPGS-NIR was 8 mg/kg body
weight (i.v.).
2.6. MSOT Image reconstruction and analysis
For in vivo MSOT measurements, motion binning was applied to
all acquired frames [14]. In this step, the 100 frames recorded for
each wavelength were separated into 3 different clusters
corresponding to respiration, ventricular systole, and diastole.
This clustering was performed by a k-means algorithm based on
manually selected seed images for each phase. Subsequently, the
mean images for each cluster, representing deblurred images for
each phase, were used for further processing and analysis. For
isolation of image contributions from dPGS-NIR, independent
component analysis (ICA) was applied [22]. This algorithm
separates the multispectral data into images comprising a set of
maximally statistically independent source components. The
source component corresponding to the unique absorption
spectrum of dPGS-NIR (Fig. 1) was in each case selected from
the ICA results by inspection. We performed analysis of the
changes in signal intensity over time by ﬁrst manually selecting a
region corresponding to the entire heart, and subsequently
automatically segmenting those pixels for each time point where
the signal corresponding to dPGS-NIR was higher than twice the
standard deviation from the mean.
2.7. Ex vivo macroscopic and histological validation
To validate the dPGS-NIR distribution imaged by MSOT, we
performed ex vivo ﬂuorescence cryoslicing imaging (FCSI) [23].
This method provides slice images in the same orientation
(transverse plane) and at the same scale as MSOT, showing both
anatomy (color) and dPGS-NIR distribution (NIRF). To this end, the
same mice imaged by MSOT were euthanized by Ketamine
overdose after the last imaging time point and then frozen at
80 8C embedded in optimal cutting temperature compound. They
were subsequently sliced in a cryotome ﬁtted with a multispectral
ﬂuorescence imaging system. Color as well as ﬂuorescence images
to detect dPGS-NIR were recorded at 250 mm intervals.
Histological analysis was applied to hearts harvested from the
same model used for MSOT imaging to validate the speciﬁcFig. 1. dPGS-NIR absorption spectrum characterized in spectrometer (solid line), by
optoacoustic phantom measurements (triangles) and by MSOT in vivo (circles). The
values are all given relative to their peaks.distribution of dPGS in the context of myocardial infarction at a
microscopic scale. dPGS-ICC was employed for histology as a
substitute for dPGS-NIR, allowing more sensitive microscopic
detection by visible ﬂuorescence light emission. dPG-ICC was used
as a nonspeciﬁc control agent in further animals. The experimental
protocol was the same as for in vivo imaging: mice were injected
with dPGS-ICC or dPG-ICC on day 2 following myocardial infarction
and sacriﬁced 2 h following injection. Following resection, the
hearts were immediately frozen in liquid nitrogen. The frozen
hearts were cut into serial coronal sections of 12 mm thickness.
Slices were stained with hematoxylin and eosin stain (H&E) or used
for ﬂuorescence microscopy. Fluorescence images were captured
using an Axio Imager Z1 upright microscope system (Carl Zeiss,
Oberkochen, Germany). The ﬂuorescent agents were detected with
a 43 HE DsRed ﬁlter set (Carl Zeiss). Nuclei were identiﬁed with
Hoechst 33342 (ﬁlter set 49 DAPI, Carl Zeiss).
3. Results
3.1. Agent spectrum
Fig. 1 depicts the dPGS-NIR spectrum measured in a spectrom-
eter and detected optoacoustically both in phantom experiments
and in vivo. The peak optical absorption coefﬁcient of the solution
measured by the spectrometer was 0.3 cm1 at 790 nm. The
spectrum is characterized by a rapid drop in absorption to values
less than 10% of the peak by 900 nm. The MSOT-derived spectrum
closely matches the absorption spectrum measured by the
spectrometer. This result is expected, since the optoacoustic
signal amplitude is proportional to the local absorption coefﬁcient,
and conﬁrms also the effectiveness of the unmixing algorithm
(ICA) applied in vivo.
3.2. In vivo detection by MSOT
Inspection of the high-resolution MSOT images reveals anatomi-
cal structures including the anterior myocardium of the left and right
ventricle (Fig. 2a and b). Endogenous tissue contrast, which is largely
derived from light absorption by hemoglobin, is lower in the infarct
region than elsewhere in the myocardium, attributed to a reduced
local hemoglobin concentration. MSOT provided multispectral
detection of dPGS-NIR in the injured myocardium in vivo
(Fig. 2b), as validated ex vivo by NIRF on a corresponding cryosection
(Fig. 2d). The agent was additionally detected both by MSOT and
cryosection NIRF in the region of surgical thoracotomy. Accumula-
tion in the scar is likely to be a result of post-surgery wound healing
which is also characterized by an increased selectin expression and
inﬂux of leukocytes into the damaged tissue.
MSOT measurements at multiple time points post-injection
provide information on the pharmacokinetic proﬁle of the agent
accumulation in the infarcted myocardium (Fig. 3). By taking the
mean of the pixels where the single intensity from dPGS-NIR was
more than twice the standard deviation from the mean for the entire
heart, we found an increase in dPGS signal strength in the injured
myocardium between the 15 min and 1 h time points, and a further
slight increase between the 1 h and 2 h time points (Fig. 3d). Imaging
time points prior to injection resulted in no detected spectral source
components corresponding to dPGS-NIR, thus resulting in a baseline
value of zero in the absence of the agent.
3.3. Histology
Areas of myocardial infarction were identiﬁed according to
established histopathological criteria. Analysis of histological
images from H&E stained slices showed large infarcted regions
(Fig. 4a). In contrast to vital myocardial tissue, tissue in the area of
Fig. 2. Transverse slice images through site of ligation in mouse model of myocardial infarction. (a) Optoacoustic image taken at 900 nm. White dotted line indicates the left
ventricle. L-region of ligation. RV-right ventricle, LV-left ventricle. Note the dark area around the ligation caused by reduced hemoglobin concentrations. (b) MSOT image.
Spectrally unmixed signal from dPGS-NIR (green) superimposed on optacoustic image taken at 900 nm. M-infarcted myocardium. (c) Color photograph of corresponding
cryosection (ex vivo) for validation. The ligation is visible. Labels the same as in (a). (d) Near infrared ﬂuorescence (NIRF, green) from dPGS-NIR superimposed on color
photograph of cryosection. dPGS-NIR is found in the infarcted myocardium as well as regions in the thoracic wall injured during surgery.
Fig. 3. Transverse slices over time through the chest of a mouse at day 2 following myocardial infarction. (a) MSOT image recorded 15 min after injection showing dPGS-NIR
signal superimposed in green over image taken at 900 nm. Arrow indicates site of infarction. (b) 1 hour after injection. (c) 2 h after injection. (d) Mean pixel intensity of MSOT
dPGS-NIR channel in pixels more than 2 standard deviations above the mean for the entire heart.
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loss of nuclei and striation, increased inﬁltration of leukocytes and
disintegration of dead muscle ﬁbers (Fig. 4a). On a larger scale,
ﬂuorescence from dPGS-ICC was observed in the infarcted regions
predominantly from the penumbral (border) zones (Fig. 4b). dPGS-
ICC ﬂuorescence was also found to originate from endothelial cells
of blood vessels (Fig. 4c and d) and from leukocytes (Fig. 4e and f) in
close association with the infarcted area, which are known to
express P- and L-selectin respectively [24,25]. The images are thus
consistent with targeting of dPGS to P- and L-selectin as previously
described in models of arthritis [17,18]. In samples treated with
the nonspeciﬁc control agent, dPG-ICC, no signal was observed
(Fig. 4g and h).
4. Discussion
In this report we demonstrated in vivo MSOT imaging of murine
myocardial infarction using a selectively targeted optical contrastagent. A spatial resolution below 200 mm is attained at penetration
depths of several millimeters, which is not possible using
conventional optical imaging [5]. As a comparison, purely optical
approaches, such as FMT, attain spatial resolutions on the order of
1 mm in mice. The strong absorption peak near 800 nm provided
by the NIR dye enables MSOT to distinguish dPGS-NIR from the
tissue background by statistical means (ICA). Endogenous hemo-
globin contrast provides anatomical reference information that can
be used to distinguish between signals originating in the injured
myocardium from other regions, such as the surgical wound in the
thoracic wall.
A further characteristic of the MSOT method as applied here is
the high temporal resolution. Parallel detection of optoacoustic
signals provided high-rate imaging: each image frame was
acquired in less than 40 microseconds whereby the overall
frame-rate was deﬁned by the laser pulse repetition at 10 frames
per second. Since the individual frames have acquisition times in
tens of microseconds, motion blurring on each image collected is
Fig. 4. Histological validation using dPGS-ICC for red emission. (a–f) Animal injected with L- and P-selectin speciﬁc dPGS-ICC. (g–h) Animal injected with nonspeciﬁc dPG-ICC.
(a) Penumbral region of the myocardial infarct, H&E, 200x. Scale bar 100 mm. (b) dPGS-ICC ﬂuorescence signal in the border region of the myocardial infarct, Fluorescence
image, 200. Scale bar 20 mm. (c) Blood vessel in the myocardium, H&E, 400. Scale bar 50 mm. (d) Fluorescence image of a blood vessel in the myocardium, 400
magniﬁcation, showing dPSG-ICC signal originating from endothelial cells. (e) Inﬁltration of leukocytes into the infarcted area, H&E, 400. Scale bar 50 mm. (f) dPGS-ICC signal
originating from leukocytes, Fluorescence image, 630. Scale bar 20 mm. (g) Border region of the myocardial infarct, H&E, 200. Scale bar 100 mm. (h) dPG-ICC ﬂuorescence
signal in the border region of the myocardial infarct, Fluorescence image, 200. The nonspeciﬁc agent shows insigniﬁcant accumulation compared to dPGS-ICC.
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second, each frame only captures signals from less than 1/2000 of
the heart’s periodic cycle and an even smaller part of the
respiratory cycle. When multiple frames were averaged, inter-
frame motion blurring was reduced by grouping frames from
similar phases of motion. The imaging protocol applied in this
study captured 100 frames at each of 8 wavelengths, resulting in atotal acquisition time of 80 s per multispectral 2D slice. In the case
of dPGS-NIR, imaging at multiple time points after injection can
provide information on the kinetics of the agent.
The histological validation revealed accumulation of dPGS
consistent with the expression proﬁles of P- and L-selectin
previously reported [24,25]. Activated leukocytes express
L-selectin during various inﬂammatory conditions, enabling their
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leukocyte adhesion molecule cascade. Correspondingly, activated
endothelial cells require P-selectin to recruit leukocytes. Leuko-
cytes recruited to the site of infarction, as well as endothelial cells
within the infarcted region, displayed dPGS-ICC signals. This
inﬂammation targeting is consistent with previous reports of dPGS
afﬁnity to P- and L-selectins in inﬂammatory [17] and diagnostic
imaging applications [18] for arthritis. A nonspeciﬁc control agent
devoid of sulfate functions responsible for selectin afﬁnity did not
show accumulation in the infarct area.
MSOT demonstrated sufﬁcient sensitivity to detect dPGS in the
myocardial infarct. From calibrated NIRF measurements (charac-
terization not shown), we estimate the concentration of dPGS-NIR
in the region of myocardial infarction to be in the range of 50–
100 mg/ml. Potentially, MSOT contrast can be increased in general
by adding multiple dyes to each targeting ligand as in this work, or
by employing strongly light-absorbing nanoparticles such as
carbon nanotubes [26] or gold nanospheres [12].
A limitation of the current MSOT implementation is that only
one 2D slice can be imaged at one time. Quantiﬁcation of signals in
the volume of the myocardium would be more accurate in a true
3D geometry, where a volume of interest would be imaged with an
isotropic spatial resolution for each laser pulse. Such systems,
which are under development, will require more transducer
elements and therefore increased acquisition complexity and
processing power.
In summary, we have shown that MSOT in combination with an
exogenous optical agent is capable of in vivo imaging of myocardial
infarction in mice at high resolutions that are not degraded by the
strong scattering of light in tissue. This and related approaches
have potential practical applications in preclinical research. Small
animal studies of myocardial infarction could apply MSOT together
with targeted agents to further investigate biological processes
during myocardial healing in vivo and to evaluate novel
therapeutic strategies. Biomarkers in other conditions such as
atherosclerosis, arthritis or cancer could be studied by the same
technique. MSOT imaging could eventually ﬁnd diverse use in
clinical settings. Potential applications include the examination of
inﬂammation in atherosclerotic plaques in relatively superﬁcial
arteries, or via an intravascular imaging approach.
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